Literature DB >> 11882997

Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus.

K N Bossart1, L F Wang, B T Eaton, C C Broder.   

Abstract

Hendra virus (HeV) is an emerging paramyxovirus first isolated from cases of severe respiratory disease that fatally affected both horses and humans. Understanding the mechanisms of host cell infection and cross-species transmission is an important step in addressing the risk posed by such emerging pathogens. We have initiated studies to characterize the biological properties of the HeV envelope glycoproteins. Recombinant vaccinia viruses encoding the HeV F and G open reading frames were generated and glycoprotein expression was verified by metabolic labeling and detection using specific antisera. Glycoprotein function and cellular tropism were examined with a quantitative assay for HeV-mediated membrane fusion. Fusion specificity was verified through specific inhibition by anti-HeV antiserum and a peptide corresponding to one of the alpha-helical heptad repeats of F. HeV requires both F and G to mediate fusion. Permissive target cells have been identified, including cell lines derived from cat, bat, horse, human, monkey, mouse, and rabbit. Fusion negative cell types have also been identified. Protease treatments of the target cells abolished fusion activity, suggesting that the virus is employing a cell-surface protein as its receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11882997     DOI: 10.1006/viro.2001.1158

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  Side chain packing below the fusion peptide strongly modulates triggering of the Hendra virus F protein.

Authors:  Everett Clinton Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

2.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Role of N-linked glycosylation of the Hendra virus fusion protein.

Authors:  James Richard Carter; Cara Theresia Pager; Stephen Derrick Fowler; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Surface density of the Hendra G protein modulates Hendra F protein-promoted membrane fusion: role for Hendra G protein trafficking and degradation.

Authors:  Shannon D Whitman; Rebecca Ellis Dutch
Journal:  Virology       Date:  2007-02-27       Impact factor: 3.616

5.  Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling.

Authors:  Hector C Aguilar; Kenneth A Matreyek; Daniel Y Choi; Claire Marie Filone; Sophia Young; Benhur Lee
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

6.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  A conserved region between the heptad repeats of paramyxovirus fusion proteins is critical for proper F protein folding.

Authors:  Amanda E Gardner; Kimberly L Martin; Rebecca E Dutch
Journal:  Biochemistry       Date:  2007-04-07       Impact factor: 3.162

8.  Differential rates of protein folding and cellular trafficking for the Hendra virus F and G proteins: implications for F-G complex formation.

Authors:  Shannon D Whitman; Everett Clinton Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

9.  Transmembrane Domain Dissociation Is Required for Hendra Virus F Protein Fusogenic Activity.

Authors:  Kerri Beth Slaughter; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

10.  Targeted strategies for henipavirus therapeutics.

Authors:  Katharine N Bossart; John Bingham; Deborah Middleton
Journal:  Open Virol J       Date:  2007-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.